ECG: the cashflow

MyFinsight

For the quarter ending 2025-09-30, ECG had $64,459K increase in cash & cash equivalents over the period. $65,674K in free cash flow.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Net income	56,977	89,515
Amortization	-	116
Depreciation	7,292	13,901
Amortization of intangible assets	0	116
Deferred income taxes	1,606	2,305
Provision for credit losses	218	-1,729
Amortization of debt issuance costs	394	788
Stock-based compensation costs	1,918	2,870
Net unrealized gains on investments	266	300
Gain on sale of assets	1,465	3,682
Equity in earnings of unconsolidated affiliates, net of distributions	5,000	-909
Receivables	61,002	91,194
Due from related-party	0	0
Contract assets	5,975	77,453
Inventories	-95	4,302
Other current assets	-4,758	-1,577
Contract liabilities, net	39,478	23,050
Accounts payable	14,529	60,547
Due to related-party	0	0
Other current liabilities	22,074	14,268
Other noncurrent changes	539	1,284
Net cash provided by operating activities	76,170	32,470
Capital expenditures	10,496	31,623
Net proceeds from sale or disposition of property, plant and equipment	2,634	5,635
Proceeds from insurance contracts	0	2,174
Investments	99	1,872
Net cash used in investing activities	-7,961	-25,686
Repayment of long-term debt	3,750	7,500
Tax withholding on stock-based compensation	0	588
Net amounts received from mdu resources cash management program	0	0
Transfers to cehi, llc and mdu resources	0	0
Net cash used in financing activities	-3,750	-8,088
Increase (decrease) in cash, cash equivalents and restricted cash	64,459	-1,304
Cash and cash equivalents at beginning of period	86,012	-
Cash and cash equivalents at end of period	149,167	-

Unit: Thousand (K) dollars